The strong beat and raised guidance support the turnaround thesis. Traders should monitor for potential analyst upgrades and continued sequential improvement in the next quarters. Key risks include still-negative net income and exposure to tariffs and discretionary spending. The stock could re-rate if the company approaches break-even sooner than expected.
Price Chart
Executive Summary
Vera Bradley reported Q1 FY2027 results that marked the first quarter of revenue growth since Q4 FY2022, with consolidated net revenues up 7.8% YoY to $55.7M, significantly exceeding consensus estimates of $49.1M. Non-GAAP EPS of ($0.09) also beat the ($0.33) consensus by 72.7%. The company raised its operating loss improvement guidance from 40%+ to 50%+ versus the prior year, signaling continued turnaround momentum under Project Sunshine.
Key Financial Metrics
Key Facts
- First quarter of YoY revenue growth since Q4 FY2022; net revenues up 7.8% to $55.7M
- Non-GAAP EPS of ($0.09) beat consensus ($0.33) by 72.7%
- Gross margin expanded 430 bps YoY to 51.8%
- Operating loss improved 76.1% on a non-GAAP basis (from ($13.6M) to ($3.3M))
- Inventory reduced 26% YoY to $73.0M, the leanest Q1 inventory since FY2011
- FY2027 guidance: sales range $255M-$270M maintained; operating loss improvement raised to 50%+ from 40%+
- First quarter of customer growth in direct channels since calendar 2021
- No borrowings on ABL facility; cash and equivalents of $12.5M
Financial Impact
Significant earnings beat (72.7% on EPS, 13.4% on revenue) combined with raised operating loss guidance, indicating accelerating turnaround. Q1 revenue growth inflection point after multiple years of decline.
Risk Factors
- Still reporting net loss from continuing operations ($4.8M GAAP loss)
- Exposure to tariffs and raw material costs
- Reliance on discretionary consumer spending; potential macroeconomic headwinds
- Future performance of Project Sunshine transformation not guaranteed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-042374 |
| Document: vra-20260611.htm | 0001628280-26-042374 |
| Document: 0001628280-26-042374-index-headers.html | 0001628280-26-042374 |
| Document: 0001628280-26-042374-index.html | 0001628280-26-042374 |
| Document: 0001628280-26-042374.txt | 0001628280-26-042374 |
| 8-K Data (Synthetic) | 0001628280-26-042374 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 4d ago | SC 13G | $6.07 | awaiting T+60 | — | $5.91 (−2.64%) |
Sep 30, 2026 26d ago | Court Ruling | $4.98 | awaiting T+60 | — | $5.91 (+18.67%) |
Sep 15, 2026 5w ago | 8-K | $4.09 | awaiting T+60 | — | $5.91 (+44.50%) |
Sep 15, 2026 5w ago | Press Release | $4.09 | awaiting T+60 | — | $5.91 (+44.50%) |
Jun 16, 2026 18w ago | Insider Cluster | $3.77 $3.14 | ▼ −16.71% | ▼ −19.86% | $5.91 (+56.76%) |
Jun 11, 2026 19w ago | 8-K | $3.46 $3.35 | ▼ −3.18% | ▼ −7.57% | $5.91 (+70.81%) |
Apr 24, 2026 26w ago | 8-K | $3.94 $3.81 | ▼ −3.30% | ▼ −8.38% | $5.91 (+50.00%) |
Apr 17, 2026 27w ago | 8-K | $4.22 $4.01 | ▼ −4.98% | ▼ −11.75% | $5.91 (+40.05%) |
Apr 17, 2026 27w ago | Press Release | $4.22 $4.01 | ▼ −4.98% | ▼ −11.75% | $5.91 (+40.05%) |
Mar 12, 2026 32w ago | 8-K | $3.38 $3.08 | ▼ −8.88% | ▼ −19.57% | $5.91 (+74.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers